NCT05912972 Development and Management of Registry in Patients With Gynecologic Cancer in Korea
| NCT ID | NCT05912972 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Asan Medical Center |
| Condition | Cervical Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 13,500 participants |
| Start Date | 2022-10-21 |
| Primary Completion | 2027-10-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 13,500 participants in total. It began in 2022-10-21 with a primary completion date of 2027-10-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to identify and analyze the characteristics, treatment trends, prognostic factors and survival prognosis of Korean gynecologic cancer patients. Ultimately, the final goal is to contribute to the development of safe surgical methods and treatment for gynecologic cancer to improve survival rates.
Eligibility Criteria
Inclusion Criteria: * Female patients 18 years or older * Written informed consent (prospective cohort) * Confirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer Exclusion Criteria: * Unconfirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer
Contact & Investigator
Jeong-Yeol Park, PhD
PRINCIPAL INVESTIGATOR
Asan Medical Center
Frequently Asked Questions
Who can join the NCT05912972 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Cervical Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05912972 currently recruiting?
Yes, NCT05912972 is actively recruiting participants. Contact the research team at obgyjypark@amc.seoul.kr for enrollment information.
Where is the NCT05912972 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT05912972 clinical trial?
NCT05912972 is sponsored by Asan Medical Center. The principal investigator is Jeong-Yeol Park, PhD at Asan Medical Center. The trial plans to enroll 13,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.